| Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned? | |
| | |
MedLine Citation:
|
PMID: 11967825 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACE-I) have different modes of action and different durations of inhibition. The effects of ACE-I on the various components of the renin-angiotensin system (RAS) at trough hours were studied in patients with diabetes mellitus receiving long-term ACE-I treatment. METHODS: Out of 86 Type 1 and 2 diabetic patients, 49 were untreated, 25 received captopril and 12 received enalapril as chronic treatment. Blood for the determination of plasma renin activity (PRA), serum ACE activity and plasma angiotensin II (Ang II) was drawn in the morning (0700-0900 hours) after an overnight fast, about 12 hours after the last dose. PRA and Ang II were measured by RIA and serum ACE activity was assayed by a radiometric assay using (3)H-hippuryl-glycyl-glycine as a substrate. RESULTS: Mean age was significantly greater in the enalapril-treated patients. Systolic and diastolic blood pressures were not different between the captopril-treated and untreated groups. Serum ACE activity in the captopril-treated diabetic patients was 101.5+/-42.5 nmol/mL/min, values obtained in untreated diabetic patients (101.4+/-25.2 nmol/mL/min). In contrast, ACE activity in the enalapril-treated patients was significantly reduced (5.5+/-7.5 nmol/mL/min) compared with untreated and captopril-treated patients (p<0.00001). PRA values in the ACE-I treated patients were significantly increased. Plasma Ang II levels were significantly increased in the captopril-treated vs. untreated patients (65.1+/-50.2 vs. 36.2+/-31.7 pg/mL, p=0.006), whereas the values in the enalapril-treated patient were slightly, but not significantly, reduced (23.8+/-21.4 pg/mL). CONCLUSIONS Trough serum ACE activity is not suppressed in diabetic patients receiving captopril, compared with those receiving enalapril and we thus question the use of short acting ACE-I in these patients. |
| | |
Authors:
|
A Erman; G Boner; D J van Dijk |
Related Documents
:
|
11692185 - Quantification of beta-cell function during ivgtt in type ii and non-diabetic subjects:... 1743805 - Influence of type i and type ii diabetes mellitus on phenytoin steady-state levels. 11270675 - Regulation of protein kinase c by short term hyperglycaemia in human platelets in vivo ... 12663475 - Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct ro... 3732135 - Synergistic actions of estradiol and the insulin-like growth factor somatomedin-c on sw... 9203445 - Low prevalence of antibodies to gad65 in a 50- to 74-year-old general dutch population.... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article |
Journal Detail:
|
Title: Journal of the renin-angiotensin-aldosterone system : JRAAS Volume: 1 ISSN: 1470-3203 ISO Abbreviation: J Renin Angiotensin Aldosterone Syst Publication Date: 2000 Dec |
Date Detail:
|
Created Date: 2002-04-22 Completed Date: 2002-06-06 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 100971636 Medline TA: J Renin Angiotensin Aldosterone Syst Country: England |
Other Details:
|
Languages: eng Pagination: 365-8 Citation Subset: IM |
Affiliation:
|
Institute of Hypertension and Kidney Diseases, Tel-Aviv University, Tel-Aviv, 49100, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Angiotensin II / blood Angiotensin-Converting Enzyme Inhibitors / therapeutic use* Captopril / therapeutic use* Diabetes Mellitus, Type 1 / blood, drug therapy* Diabetes Mellitus, Type 2 / blood, drug therapy* Enalapril / therapeutic use* Humans Middle Aged Peptidyl-Dipeptidase A / blood Renin / blood Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 11128-99-7/Angiotensin II; 62571-86-2/Captopril; 75847-73-3/Enalapril; EC 3.4.15.1/Peptidyl-Dipeptidase A; EC 3.4.23.15/Renin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Acute effects of ACE inhibition on coronary endothelial dysfunction.
Next Document: Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction.